Report DMCA Absence of QTc prolongation in a thorough QT study with imeglimin, a first in class oral agent for type 2 diabetes melli
* Please fill this form as much details as possible, we will respond to your request within 2 to 3 business days.
* Please fill this form as much details as possible, we will respond to your request within 2 to 3 business days.